Jazz Pharma Enrolls First Patient In Phase 2 Trial Of JZP150 For Post-Traumatic Stress Disorder - Nasdaq

Submitted by Anonymous (not verified) on Thu, 12/30/2021 - 13:03

Jazz Pharma Enrolls First Patient In Phase 2 Trial Of JZP150 For Post-Traumatic Stress Disorder  Nasdaq